RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sartorius Stedim Biotech Stock

Sartorius Stedim Biotech ROE 2024

Sartorius Stedim Biotech ROE

0.12

Ticker

DIM.PA

ISIN

FR0013154002

WKN

A2AJKS

In 2024, Sartorius Stedim Biotech's return on equity (ROE) was 0.12, a -67.18% increase from the 0.36 ROE in the previous year.

Sartorius Stedim Biotech Aktienanalyse

What does Sartorius Stedim Biotech do?

Sartorius Stedim Biotech SA is a company specializing in the development, manufacturing, and marketing of products and services for the biopharmaceutical industry. It was formed in 2007 through the merger of two companies, Sartorius and Stedim Biotech, and is headquartered in Aubagne, France. The company has a history dating back to 1870 when Florenz Sartorius, a mechanic, founded a precision scale factory in Göttingen, Germany. Over the years, Sartorius became a leading provider of laboratory scales and equipment worldwide. In 1951, the company was renamed Sartorius AG and expanded into filtration technology. Stedim Biotech, on the other hand, was founded in 1957 as a manufacturer of plastic products and is based in Aubagne, France. It has since become a leading provider of products and services for the biopharmaceutical industry. Today, Sartorius Stedim Biotech SA operates in four business segments: bioprocess systems, laboratory equipment, services, and specialized products. Its bioprocess systems segment includes products and solutions for biopharmaceutical production such as fermenters, bioreactors, cryogenic storage tanks, and filtration systems. The laboratory equipment segment offers a wide range of lab products including scales, pipettes, and analysis devices. The services segment includes consulting, training, and technical services for the biopharmaceutical industry. Lastly, the specialized products segment provides a broad range of products for specific applications, such as disposable syringes for medication administration. Sartorius Stedim Biotech SA has developed a wide range of products for the biopharmaceutical industry, including fermenters and bioreactors for the production of biological drugs, filtration systems for protein purification and cell culture media, disposable syringes for medication administration, and laboratory equipment for sample analysis. The company's business model is to offer a comprehensive range of products and services for the biopharmaceutical industry. It focuses on high-quality and innovative products and services, as well as providing consultation and support to its customers in solving challenges in biopharmaceutical production. Overall, Sartorius Stedim Biotech SA is a leading provider of products and services for the biopharmaceutical industry. Its broad product range and consultancy and support services make it an important partner for the biopharmaceutical industry in the production of biological drugs. Sartorius Stedim Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Sartorius Stedim Biotech's Return on Equity (ROE)

Sartorius Stedim Biotech's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Sartorius Stedim Biotech's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Sartorius Stedim Biotech's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Sartorius Stedim Biotech’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Sartorius Stedim Biotech stock

What is the ROE (Return on Equity) of Sartorius Stedim Biotech this year?

The ROE of Sartorius Stedim Biotech this year is 0.12 undefined.

How has the Return on Equity (ROE) of Sartorius Stedim Biotech developed compared to the previous year?

The ROE of Sartorius Stedim Biotech has increased by -67.18% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Sartorius Stedim Biotech?

A high ROE indicates that Sartorius Stedim Biotech generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Sartorius Stedim Biotech?

A low ROE can indicate that Sartorius Stedim Biotech is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Sartorius Stedim Biotech affect the company?

A change in ROE (Return on Equity) of Sartorius Stedim Biotech can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Sartorius Stedim Biotech?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Sartorius Stedim Biotech?

Some factors that can influence Sartorius Stedim Biotech's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Sartorius Stedim Biotech pay?

Over the past 12 months, Sartorius Stedim Biotech paid a dividend of 2.88 EUR . This corresponds to a dividend yield of about 1.68 %. For the coming 12 months, Sartorius Stedim Biotech is expected to pay a dividend of 3.69 EUR.

What is the dividend yield of Sartorius Stedim Biotech?

The current dividend yield of Sartorius Stedim Biotech is 1.68 %.

When does Sartorius Stedim Biotech pay dividends?

Sartorius Stedim Biotech pays a quarterly dividend. This is distributed in the months of April, April, April, May.

How secure is the dividend of Sartorius Stedim Biotech?

Sartorius Stedim Biotech paid dividends every year for the past 27 years.

What is the dividend of Sartorius Stedim Biotech?

For the upcoming 12 months, dividends amounting to 3.69 EUR are expected. This corresponds to a dividend yield of 2.15 %.

In which sector is Sartorius Stedim Biotech located?

Sartorius Stedim Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sartorius Stedim Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sartorius Stedim Biotech from 4/4/2024 amounting to 0.69 EUR, you needed to have the stock in your portfolio before the ex-date on 4/2/2024.

When did Sartorius Stedim Biotech pay the last dividend?

The last dividend was paid out on 4/4/2024.

What was the dividend of Sartorius Stedim Biotech in the year 2023?

In the year 2023, Sartorius Stedim Biotech distributed 2.52 EUR as dividends.

In which currency does Sartorius Stedim Biotech pay out the dividend?

The dividends of Sartorius Stedim Biotech are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Sartorius Stedim Biotech stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Sartorius Stedim Biotech

Our stock analysis for Sartorius Stedim Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sartorius Stedim Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.